title: [Lymph node pathology - an update].
abstract: Immune suppression is a risk factor for malignant lymphoma development. Progress in medical science has increased the numbers of immunosuppressed patients due to organ transplantations or successful treatment of autoimmune diseases. Different forms of immune suppression and the respective lymphoma entities are discussed in this article. Another issue treated are gray zone lymphomas between Hodgkin's lymphoma and diffuse large B cell lymphoma. This category not only represents a diagnostic challenge but also represents more a true biological continuum.
authors: Senckenbergisches Institut für Pathologie, Klinikum der J. W. Goethe-Universität, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Deutschland. s.hartmann@em.uni-frankfurt.de
authors: S
authors: S
authors: Hartmann
authors: M L
authors: ML
authors: Hansmann
mesh_terms: D001327:Autoimmune Diseases / Q000188:drug therapy / Q000235:genetics / Q000276:immunology / Q000473:pathology; D014408:Biomarkers, Tumor / Q000235:genetics; D001706:Biopsy; D003937:Diagnosis, Differential; D015972:Gene Expression Regulation, Neoplastic / Q000235:genetics; D005819:Genetic Markers / Q000235:genetics; D006689:Hodgkin Disease / Q000145:classification / Q000235:genetics / Q000276:immunology / Q000473:pathology; D006801:Humans; D007108:Immune Tolerance / Q000276:immunology; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects; D008198:Lymph Nodes / Q000276:immunology / Q000473:pathology*; D008223:Lymphoma / Q000145:classification / Q000235:genetics / Q000276:immunology / Q000473:pathology*; D016483:Lymphoma, AIDS-Related / Q000235:genetics / Q000276:immunology / Q000473:pathology; D016403:Lymphoma, Large B-Cell, Diffuse / Q000145:classification / Q000235:genetics / Q000473:pathology; D008232:Lymphoproliferative Disorders / Q000235:genetics / Q000276:immunology / Q000473:pathology; D008479:Mediastinal Neoplasms / Q000145:classification / Q000235:genetics / Q000473:pathology; D011183:Postoperative Complications / Q000235:genetics / Q000276:immunology / Q000473:pathology; D011379:Prognosis; D012307:Risk Factors; D014181:Transplantation Immunology / Q000235:genetics / Q000276:immunology
chemical_list: D014408:Biomarkers, Tumor; D005819:Genetic Markers; D007166:Immunosuppressive Agents